Guidance
List of medicines that can be moved through NIMAR
Updated 2 July 2026
Download CSV 997 Bytes
| Brand name | Generic name | Date added |
|---|---|---|
| Amversio oral powder | Betaine oral powder | 11/04/2024 |
| Apretude 600mg/3ml prolonged-release suspension for injection vials | Cabotegravir 600mg/3ml prolonged-release suspension for injection vials | 19/11/2025 |
| Not applicable | Canagliflozin 100mg tablets | 04/02/2025 |
| Not applicable | Doxepin 5% cream | 16/12/2021 |
| Not applicable | Filsuvez gel | 05/01/2024 |
| Arava 10mg tablets | Leflunomide 10mg tablets | 01/09/2023 |
| Not applicable | Levomepromazine hydrochloride 25mg/5ml oral solution sugar free | 19/04/2024 |
| Atriance 250mg/50ml solution for infusion vials | Nelarabine 250mg/50ml solution for infusion vials | 27/04/2026 |
| Not applicable | Rivastigmine 6mg capsules | 16/12/2021 |
| Not applicable | Silver Sulfadiazine 1% cream | 08/06/2022 |
| Talzenna 1mg capsules | Talazoparib 1mg capsules | 27/12/2024 |
| Not applicable | Topotecan 1mg capsules | 05/04/2022 |
| Not applicable | Toremifine 60mg tablets | 08/09/2022 |
| Not applicable | Verteporfin 15mg powder for solution for infusion vials | 23/04/2025 |